European Society of Cardiology
Skip navigation links
Home
About the ESC
Membership
Communities
Congresses
Education
Guidelines & Surveys
Journals
Initiatives
Welcome to the European Society of Cardiology. Our mission: to reduce the burden of cardiovascular disease in Europe
 

ESC Congresses

During the ESC Congress, EHRA members have actively participated in the different sessions dedicated to topics in our field of expertise.

Find resources from the ESC Congresses on your field(s) of interest

 ESC Congress 2011  | ESC Congress 2010ESC Congress 2009 | ESC Congress 2008

18/09/2009 00:00:00

 ESC Congress 2011 - Paris


FPnumberPresentationSpeakerTopicDate
1035Electrophysiology in 2011: visions and challengesEvolving medical antiarrhythmic treatment targets: ready for clinical practice?DO.Arnar ( Reykjavik-Iceland)Arrhythmias / Pacing / Resynchronisation28 Aug 2011
1037Electrophysiology in 2011: visions and challengesProphylactic catheter ablation of VT in patients with structural heart disease: ready to reduce morality?H.Kottkamp ( Zurich-Switzerland)Arrhythmias / Pacing / Resynchronisation28 Aug 2011
1038Electrophysiology in 2011: visions and challengesMultimodality optimised lead positioning to reduce CRT non responders: ready for prime time?OA.Breithardt ( Erlangen-Germany)Arrhythmias / Pacing / Resynchronisation28 Aug 2011
1157Clinical Trial Update I - Drug treatmentARISTOTLE: Efficacy and safety of Apixaban compared to Warfarin at different levels of INR control for stroke prevention in 18,202 patients with atrial fibrillation in the ARISTOTLE trialL C.Wallentin ( Uppsala-Sweden)Arrhythmias / Pacing / Resynchronisation28 Aug 2011
1159Clinical Trial Update I - Drug treatmentROCKET AF: Prevention of stroke and systemic embolism using the oral direct factor Xa inhibitor Rivaroxaban compared with Warfarin in patients with nonvalvular atrial fibrillation and moderate renal impairmentK A A.Fox ( Edinburgh-United Kingdom)Arrhythmias / Pacing / Resynchronisation28 Aug 2011
1160Clinical Trial Update I - Drug treatmentDiscussant - ROCKET AF: Prevention of stroke and systemic embolism using the oral direct factor Xa inhibitor Rivaroxaban compared with Warfarin in patients with nonvalvular atrial fibrillation and moderate renal impairmentS H.Hohnloser ( Frankfurt-Germany)Arrhythmias / Pacing / Resynchronisation28 Aug 2011
1161Clinical Trial Update I - Drug treatmentRE-LY: Concomitant use of antiplatelet therapy with dabigatran or warfarin in the randomized evaluation of long-term anticoagulation therapy (RE-LY®) trialAM.Dans ( Manila-Philippines)Arrhythmias / Pacing / Resynchronisation28 Aug 2011
1162Clinical Trial Update I - Drug treatmentDiscussant - RE-LY: Concomitant use of antiplatelet therapy with dabigatran or warfarin in the randomized evaluation of long-term anticoagulation therapy (RE-LY®) trialFWA.Verheugt ( Amsterdam-Netherlands)Arrhythmias / Pacing / Resynchronisation28 Aug 2011
1208Electrocardiogram - still a challenge?Electrocardiogram tracings.J L R M.Smeets ( Nijmegen-Netherlands)Arrhythmias / Pacing / Resynchronisation28 Aug 2011
1210Electrocardiogram - still a challenge?Electrocardiogram tracings.J.Brugada Terradellas ( Barcelona-Spain)Arrhythmias / Pacing / Resynchronisation28 Aug 2011
1268The challenge of arrhythmias in athletesThe frontier between normal and abnormal ectrocardiogram in athletes.F.Carre ( Rennes Cedex-France)Arrhythmias / Pacing / Resynchronisation28 Aug 2011
1269The challenge of arrhythmias in athletesAtrial fibrillation in athletes: clinical relevance and management.L.Mont ( Barcelona-Spain)Arrhythmias / Pacing / Resynchronisation28 Aug 2011
1270The challenge of arrhythmias in athletesVentricular arrhythmias: who is at risk?A.Steinvil ( Tel-Aviv-Israel)Arrhythmias / Pacing / Resynchronisation28 Aug 2011
1271The challenge of arrhythmias in athletesManagement of syncope in athletes.L.Eckardt ( Munster-Germany)Arrhythmias / Pacing / Resynchronisation28 Aug 2011
1353CRH I - Risk and treatment reality"Atrial fibrillation ablation" European survey: short-term results.J.Brugada Terradellas ( Barcelona-Spain)Arrhythmias / Pacing / Resynchronisation28 Aug 2011
1355CRH I - Risk and treatment realityGlobal variation in the etiology and management of atrial fibrillation: results from a global atrial fibrillation registryJ.Healey ( Hamilton-Canada)Arrhythmias / Pacing / Resynchronisation28 Aug 2011
413Hot Line I - Cardiovascular risk and complicationsARISTOTLE: Efficacy and safety of Apixaban compared to Warfarin for prevention of stroke and systemic embolism in 18,202 patients with atrial fibrillation: primary results of the ARISTOTLE trialC B.Granger ( Durham-United States of America)Arrhythmias / Pacing / Resynchronisation28 Aug 2011
414Hot Line I - Cardiovascular risk and complicationsDiscussant - ARISTOTLE: Efficacy and safety of Apixaban compared to Warfarin for prevention of stroke and systemic embolism in 18,202 patients with atrial fibrillation: primary results of the ARISTOTLE trialM D.Ezekowitz ( Villanova-United States of America)Arrhythmias / Pacing / Resynchronisation28 Aug 2011
942Cardiac resynchronisation therapy: from patient selection to monitorisationThe case of "non-left bundle branch block" QRS morphology: when should I consider cardiac resynchronisation therapy?C.Linde ( Stockholm-Sweden)Arrhythmias / Pacing / Resynchronisation28 Aug 2011
944Cardiac resynchronisation therapy: from patient selection to monitorisationRecurrent atrial fibrillation in a cardiac resynchronisation therapy patient: role of remote monitoring for management strategy.H.Burri ( Geneva-Switzerland)Arrhythmias / Pacing / Resynchronisation28 Aug 2011
1897New evidence beyond guidelines in atrial fibrillationNew developments in the diagnosis of atrial fibrillation.G.Hindricks ( Leipzig-Germany)Arrhythmias / Pacing / Resynchronisation29 Aug 2011
1898New evidence beyond guidelines in atrial fibrillationNew antithrombotic therapies: revisiting stroke prevention in atrial fibrillation.L C.Wallentin ( Uppsala-Sweden)Arrhythmias / Pacing / Resynchronisation29 Aug 2011
1900New evidence beyond guidelines in atrial fibrillationWill catheter ablation of atrial fibrillation withstand the test of randomised studies.S.Ernst ( London-United Kingdom)Arrhythmias / Pacing / Resynchronisation29 Aug 2011
2175Hot Line II - Frontiers in interventional and device treatmentsECOST: Safety of implantable cardioverter defibrillator follow-up using remote monitoring: a randomized controlled trialS.Kacet ( Lille Cedex-France)Arrhythmias / Pacing / Resynchronisation29 Aug 2011
2176Hot Line II - Frontiers in interventional and device treatmentsDiscussant - ECOST: Safety of implantable cardioverter defibrillator follow-up using remote monitoring: a randomized controlled trialJ C.Daubert ( Rennes-France)Arrhythmias / Pacing / Resynchronisation29 Aug 2011
2747Anti-thrombotic therapy in atrial fibrillation - difficult management scenariosStroke and bleeding risk assessment in a high risk atrial fibrillation patient who needs a coronary stent.A.Rubboli ( Bologna-Italy)Arrhythmias / Pacing / Resynchronisation29 Aug 2011
2749Anti-thrombotic therapy in atrial fibrillation - difficult management scenariosThe 'truly low stroke risk' patient with atrial fibrillation: defining the population and what to do post-ablation.L.Fauchier ( Tours-France)Arrhythmias / Pacing / Resynchronisation29 Aug 2011
2825Controversial issues in cardiac resynchronisation therapyIs the optimisation of the atrioventricular and interventricular delays useful?D.Gras ( Nantes Cedex 2-France)Arrhythmias / Pacing / Resynchronisation29 Aug 2011
2826Controversial issues in cardiac resynchronisation therapyHow to manage cardiac resynchronisation therapy in atrial fibrillation patients?E K.Heist ( Boston-United States of America)Arrhythmias / Pacing / Resynchronisation29 Aug 2011
2827Controversial issues in cardiac resynchronisation therapyThe use of cardiac resynchronisation therapy outside current guidelines.RJ.van Bommel ( Leiden-Netherlands)Arrhythmias / Pacing / Resynchronisation29 Aug 2011
2920Clinical Trial Update II - Rate and rhythmPACE: Biventricular pacing superior to right ventricular pacing in bradycardia patients with preserved systolic function: two-year results of PACE trialCM.Yu ( Hong Kong-Hong Kong SAR, People's Republic of China)Arrhythmias / Pacing / Resynchronisation29 Aug 2011
2921Clinical Trial Update II - Rate and rhythmDiscussant - PACE: Biventricular pacing superior to right ventricular pacing in bradycardia patients with preserved systolic function: two-year results of PACE trialK.Dickstein ( Stavanger-Norway)Arrhythmias / Pacing / Resynchronisation29 Aug 2011
2923Clinical Trial Update II - Rate and rhythmDiscussant - IRIS: Why does the implantable cardioverter-defibrillator not improve mortality early after myocardial infarction - Insights from the Immediate Risk Stratification Improves Survival (IRIS) trialC.Leclercq ( Rennes-France)Arrhythmias / Pacing / Resynchronisation29 Aug 2011
3010State of the Art - Featured research on genetic aspects of cardiac arrhythmiasA rare variant in MYH6 confers high risk of sick sinus syndromeH.Holm ( Mosfellsbaer-Iceland)Arrhythmias / Pacing / Resynchronisation29 Aug 2011
3012State of the Art - Featured research on genetic aspects of cardiac arrhythmiasA dominant negative missense mutation in MOG1 induces trafficking defect of cardiac sodium channel and is associated with Brugada syndrome ECG patternD.Kattygnarath ( Paris-France)Arrhythmias / Pacing / Resynchronisation29 Aug 2011
3014State of the Art - Featured research on genetic aspects of cardiac arrhythmiasState of the Art - Featured research on genetic aspects of cardiac arrhythmiasP J.Schwartz ( Pavia-Italy)Arrhythmias / Pacing / Resynchronisation29 Aug 2011
3125CRH II - Interventions and devicesThe European CRT survey: 1 year follow-up resultsN.Bogale ( Sandnes-Norway)Arrhythmias / Pacing / Resynchronisation29 Aug 2011
3911EURObservational Research Programme of the ESC. Ongoing RegistriesSentinel Registry: Ablation in Atrial Fibrillation.J.Brugada Terradellas ( Barcelona-Spain)Arrhythmias / Pacing / Resynchronisation30 Aug 2011

 ESC Congress 2010 - Stockholm


PresentationSpeakerTopicDate
Atrial fibrillation - new insightsRole of abnormal intracellular calcium release.Xander Wehrens (US)Arrhythmias / Pacing / Resynchronisation31 Aug 2010
Atrial fibrillation - new insightsCytoskeleton reorganisation.Jan Wilko Schrickel (DE)Arrhythmias / Pacing / Resynchronisation31 Aug 2010
Atrial fibrillation - new insightsNew mechanistic insights from inherited mutations.Ramon Brugada Terradellas (ES)Arrhythmias / Pacing / Resynchronisation31 Aug 2010
Atrial fibrillation - new insightsRole of calcineurin/nuclear factor of activated T-cells signalling.Ulrich Schotten (NL)Arrhythmias / Pacing / Resynchronisation31 Aug 2010
Cardiac resynchronisation therapy: non responders or non progressors?Don't select the wrong patient.Maurizio Gasparini (IT)Arrhythmias / Pacing / Resynchronisation29 Aug 2010
Cardiac resynchronisation therapy: non responders or non progressors?Is lead placement a real issue?Ignacio Fernandez Lozano (ES)Arrhythmias / Pacing / Resynchronisation29 Aug 2010
Cardiac resynchronisation therapy: non responders or non progressors?Don't forget to optimise the device programming.Ali Oto (Turkey)Arrhythmias / Pacing / Resynchronisation29 Aug 2010
Cardiac resynchronisation therapy: non responders or non progressors?What is going to be next?Christophe Leclercq (FR)Arrhythmias / Pacing / Resynchronisation29 Aug 2010
What is behind the new ESC atrial fibrillation Guidelines?What is the place of old and new antiarrhythmic drugs?Isabelle C Van Gelder (NL)Arrhythmias / Pacing / Resynchronisation30 Aug 2010
What is behind the new ESC atrial fibrillation Guidelines?Controversies with regard to 'upstream therapy'.Barbara Casadei (UK)Arrhythmias / Pacing / Resynchronisation30 Aug 2010
What is behind the new ESC atrial fibrillation Guidelines?Lessons from recent antithrombotic studies and trials.Lars Wallentin (SE)Arrhythmias / Pacing / Resynchronisation30 Aug 2010
What is behind the new ESC atrial fibrillation Guidelines?In whom and when should atrial fibrillation ablation be considered?Christian de Chillou (FR)Arrhythmias / Pacing / Resynchronisation30 Aug 2010
Anti-thrombotic therapy in atrial fibrillation: difficult decisionsAfter successful cardioversion – for how long?George K Andrikopoulos (GR)Arrhythmias / Pacing / Resynchronisation30 Aug 2010
Anti-thrombotic therapy in atrial fibrillation: difficult decisionsSporadic or short episodes of paroxysmal atrial fibrillation – still a need for antithrombotic therapy?Carina Blomstrom-Lundqvist (SE)Arrhythmias / Pacing / Resynchronisation30 Aug 2010
Anti-thrombotic therapy in atrial fibrillation: difficult decisionsCan antithrombotic therapy be withdrawn after successful catheter ablation?Claudio Pratola (IT)Arrhythmias / Pacing / Resynchronisation30 Aug 2010
Anti-thrombotic therapy in atrial fibrillation: difficult decisionsAfter percutaneous coronary intervention in patients with atrial fibrillation.Ariel Cohen (FR)Arrhythmias / Pacing / Resynchronisation30 Aug 2010
Anti-thrombotic therapy in atrial fibrillation: difficult decisionsAfter major bleeding in patients with high risk profile and atrial fibrillation.Thomas Meinertz (DE)Arrhythmias / Pacing / Resynchronisation30 Aug 2010
Syncope in cardiology practiceAn analysis of pathophysiologies.Richard Sutton (UK)Arrhythmias / Pacing / Resynchronisation29 Aug 2010
Syncope in cardiology practiceSyncope evaluation: the role of syncope clinics.Michele Brignole (IT)Arrhythmias / Pacing / Resynchronisation29 Aug 2010
Syncope in cardiology practiceSyncope in patients without heart disease.Angel Moya I Mitjans (ES)Arrhythmias / Pacing / Resynchronisation29 Aug 2010
Syncope in cardiology practiceFalls in the elderly. Diagnostic and therapeutic approach.Stylianos Tzeis (GR)Arrhythmias / Pacing / Resynchronisation29 Aug 2010
Hot Line III - Cardiovascular disease and rhythm disturbancesDANPACE: The Danish multicenter randomised trial on single lead atrial versus dual chamber pacing in sick sinus syndromeJens Cosedis Nielsen (DK)Arrhythmias / Pacing / Resynchronisation31 Aug 2010
Hot Line III - Cardiovascular disease and rhythm disturbancesDiscussant: DANPACE: The Danish multicenter randomised trial on single lead atrial versus dual chamber pacing in sick sinus syndromeCarina Blomstrom-Lundqvist (SE)Arrhythmias / Pacing / Resynchronisation31 Aug 2010
Hot Line III - Cardiovascular disease and rhythm disturbancesANTIPAF: Angiotensin II-antagonist in paroxysmal atrial fibrillation trialAndreas Goette (DE)Arrhythmias / Pacing / Resynchronisation31 Aug 2010
Hot Line III - Cardiovascular disease and rhythm disturbancesDiscussant: ANTIPAF: Angiotensin II-antagonist in paroxysmal atrial fibrillation trialJohn Camm (UK)Arrhythmias / Pacing / Resynchronisation31 Aug 2010
Clinical Trial Update IIIPACE: Pacing to Avoid Cardiac Enlargement (PACE) studyCheuk-Man Yu (Hong Kong SAR, CN)Arrhythmias / Pacing / Resynchronisation01 Sep 2010
Clinical Trial Update IIIDiscussant: PACE: Pacing to Avoid Cardiac Enlargement (PACE) studyWilliam Abraham (US)Arrhythmias / Pacing / Resynchronisation01 Sep 2010
Clinical Trial Update IIICARE HF LTFU: Cardiac Resynchronisation in Heart Failure: Long-Term Follow-upJohn Cleland (UK)Arrhythmias / Pacing / Resynchronisation01 Sep 2010
Clinical Trial Update IIIDiscussant: CARE HF LTFU: Cardiac Resynchronisation in Heart Failure: Long-Term Follow-upOle A Breithardt (DE)Arrhythmias / Pacing / Resynchronisation01 Sep 2010
Clinical Trial Update IIIThe REALISE-AF registry: an international, observational, cross-sectional survey describing characteristics, cardiovascular risk, and management of patients with atrial fibrillationPhilippe Gabriel Steg (FR)Arrhythmias / Pacing / Resynchronisation01 Sep 2010
Clinical Trial Update IIIDiscussant: The REALISE-AF registry: an international, observational, cross-sectional survey describing characteristics, cardiovascular risk, and management of patients with atrial fibrillationJosep Brugada Terradellas (ES)Arrhythmias / Pacing / Resynchronisation01 Sep 2010
Atrial fibrillation ablation. Optimal approaches in 2010Patients with paroxysmal atrial fibrillation.Eric N Prystowsky (US)Arrhythmias / Pacing / Resynchronisation29 Aug 2010
Atrial fibrillation ablation. Optimal approaches in 2010Patients with persistent/permanent atrial fibrillation.Carlo Pappone (IT)Arrhythmias / Pacing / Resynchronisation29 Aug 2010
Atrial fibrillation ablation. Optimal approaches in 2010Repeat procedures: the best approach.Gerhard Hindricks (DE)Arrhythmias / Pacing / Resynchronisation29 Aug 2010
Atrial fibrillation ablation. Optimal approaches in 2010Surgical approach to paroxysmal/persistent atrial fibrillation.Ralph J Damiano (US)Arrhythmias / Pacing / Resynchronisation29 Aug 2010
Towards the 2010 Guidelines for ResuscitationThe 2010 evidence-based guidelines: the process, the challenges.Jerry Nolan (UK)Arrhythmias / Pacing / Resynchronisation30 Aug 2010
Towards the 2010 Guidelines for ResuscitationTherapeutic hypothermia after cardiac arrest.Bernd W Boettiger (DE)Arrhythmias / Pacing / Resynchronisation30 Aug 2010
Towards the 2010 Guidelines for ResuscitationShould we use devices for chest compression?Sten Rubertsson (SE)Arrhythmias / Pacing / Resynchronisation30 Aug 2010
Towards the 2010 Guidelines for ResuscitationPercutaneous coronary intervention after restoration of spontaneous circulation?Christian Spaulding (FR)Arrhythmias / Pacing / Resynchronisation30 Aug 2010
Towards the 2010 Guidelines for ResuscitationEuReCa: monitoring resuscitation practice in Europe.Leo L Bossaert (BE)Arrhythmias / Pacing / Resynchronisation30 Aug 2010
Take home messages for practitionersArrhythmia and pacing.Panagiotis Vardas (GR)Arrhythmias / Pacing / Resynchronisation31 Aug 2010
The new ESC GuidelinesAtrial fibrillation.John Camm (UK)Arrhythmias / Pacing / Resynchronisation29 Aug 2010
ESC Guidelines on atrial fibrillationRecommendations and anticipation of new anticoagulation strategies for atrial fibrillation.Raffaele De Caterina (IT)Arrhythmias / Pacing / Resynchronisation30 Aug 2010
ESC Guidelines on atrial fibrillationAre new guidelines for rate control needed?Isabelle C Van Gelder (NL)Arrhythmias / Pacing / Resynchronisation30 Aug 2010
ESC Guidelines on atrial fibrillationNew indications for new antiarrhythmic drugs?Dan Atar (NO)Arrhythmias / Pacing / Resynchronisation30 Aug 2010
ESC Guidelines on atrial fibrillationUpstream therapy for primary and secondary prevention.Irene Savelieva (UK)Arrhythmias / Pacing / Resynchronisation30 Aug 2010
ESC Guidelines on atrial fibrillationWhen is ablation for atrial fibrillation the preferred treatment?Gerhard Hindricks (DE)Arrhythmias / Pacing / Resynchronisation30 Aug 2010
Cardiac resynchronisation therapy: optimising patient selection with imagingAssessing mechanical dyssynchrony: echo is still alive!!!Erwan Donal (FR)Arrhythmias / Pacing / Resynchronisation29 Aug 2010
Cardiac resynchronisation therapy: optimising patient selection with imagingDo not forget the coronary sinus anatomy.Christopher Piorkowski (DE)Arrhythmias / Pacing / Resynchronisation29 Aug 2010
Forum for future leaders in cardiologyDiffuse ST segment elevation and ventricular fibrilation without structural heart disease - a new electrocardiographic presentation of a channelopathy?Ana Lebreiro (PT)Arrhythmias / Pacing / Resynchronisation31 Aug 2010
Electrophysiology in 2011: visions and challengesEvolving medical antiarrhythmic treatment targets: ready for clinical practice?DO.Arnar ( Reykjavik-Iceland)Arrhythmias / Pacing / Resynchronisation28 Aug 2011
Electrophysiology in 2011: visions and challengesProphylactic catheter ablation of VT in patients with structural heart disease: ready to reduce morality?H.Kottkamp ( Zurich-Switzerland)Arrhythmias / Pacing / Resynchronisation28 Aug 2011
Electrophysiology in 2011: visions and challengesMultimodality optimised lead positioning to reduce CRT non responders: ready for prime time?OA.Breithardt ( Erlangen-Germany)Arrhythmias / Pacing / Resynchronisation28 Aug 2011
Clinical Trial Update I - Drug treatmentARISTOTLE: Efficacy and safety of Apixaban compared to Warfarin at different levels of INR control for stroke prevention in 18,202 patients with atrial fibrillation in the ARISTOTLE trialL C.Wallentin ( Uppsala-Sweden)Arrhythmias / Pacing / Resynchronisation28 Aug 2011
Clinical Trial Update I - Drug treatmentROCKET AF: Prevention of stroke and systemic embolism using the oral direct factor Xa inhibitor Rivaroxaban compared with Warfarin in patients with nonvalvular atrial fibrillation and moderate renal impairmentK A A.Fox ( Edinburgh-United Kingdom)Arrhythmias / Pacing / Resynchronisation28 Aug 2011
Clinical Trial Update I - Drug treatmentDiscussant - ROCKET AF: Prevention of stroke and systemic embolism using the oral direct factor Xa inhibitor Rivaroxaban compared with Warfarin in patients with nonvalvular atrial fibrillation and moderate renal impairmentS H.Hohnloser ( Frankfurt-Germany)Arrhythmias / Pacing / Resynchronisation28 Aug 2011
Clinical Trial Update I - Drug treatmentRE-LY: Concomitant use of antiplatelet therapy with dabigatran or warfarin in the randomized evaluation of long-term anticoagulation therapy (RE-LY®) trialAM.Dans ( Manila-Philippines)Arrhythmias / Pacing / Resynchronisation28 Aug 2011
Clinical Trial Update I - Drug treatmentDiscussant - RE-LY: Concomitant use of antiplatelet therapy with dabigatran or warfarin in the randomized evaluation of long-term anticoagulation therapy (RE-LY®) trialFWA.Verheugt ( Amsterdam-Netherlands)Arrhythmias / Pacing / Resynchronisation28 Aug 2011
Electrocardiogram - still a challenge?Electrocardiogram tracings.J L R M.Smeets ( Nijmegen-Netherlands)Arrhythmias / Pacing / Resynchronisation28 Aug 2011
Electrocardiogram - still a challenge?Electrocardiogram tracings.J.Brugada Terradellas ( Barcelona-Spain)Arrhythmias / Pacing / Resynchronisation28 Aug 2011
The challenge of arrhythmias in athletesThe frontier between normal and abnormal ectrocardiogram in athletes.F.Carre ( Rennes Cedex-France)Arrhythmias / Pacing / Resynchronisation28 Aug 2011
The challenge of arrhythmias in athletesAtrial fibrillation in athletes: clinical relevance and management.L.Mont ( Barcelona-Spain)Arrhythmias / Pacing / Resynchronisation28 Aug 2011
The challenge of arrhythmias in athletesVentricular arrhythmias: who is at risk?A.Steinvil ( Tel-Aviv-Israel)Arrhythmias / Pacing / Resynchronisation28 Aug 2011
The challenge of arrhythmias in athletesManagement of syncope in athletes.L.Eckardt ( Munster-Germany)Arrhythmias / Pacing / Resynchronisation28 Aug 2011
CRH I - Risk and treatment reality"Atrial fibrillation ablation" European survey: short-term results.J.Brugada Terradellas ( Barcelona-Spain)Arrhythmias / Pacing / Resynchronisation28 Aug 2011
CRH I - Risk and treatment realityGlobal variation in the etiology and management of atrial fibrillation: results from a global atrial fibrillation registryJ.Healey ( Hamilton-Canada)Arrhythmias / Pacing / Resynchronisation28 Aug 2011
Hot Line I - Cardiovascular risk and complicationsARISTOTLE: Efficacy and safety of Apixaban compared to Warfarin for prevention of stroke and systemic embolism in 18,202 patients with atrial fibrillation: primary results of the ARISTOTLE trialC B.Granger ( Durham-United States of America)Arrhythmias / Pacing / Resynchronisation28 Aug 2011
Hot Line I - Cardiovascular risk and complicationsDiscussant - ARISTOTLE: Efficacy and safety of Apixaban compared to Warfarin for prevention of stroke and systemic embolism in 18,202 patients with atrial fibrillation: primary results of the ARISTOTLE trialM D.Ezekowitz ( Villanova-United States of America)Arrhythmias / Pacing / Resynchronisation28 Aug 2011
Cardiac resynchronisation therapy: from patient selection to monitorisationThe case of "non-left bundle branch block" QRS morphology: when should I consider cardiac resynchronisation therapy?C.Linde ( Stockholm-Sweden)Arrhythmias / Pacing / Resynchronisation28 Aug 2011
Cardiac resynchronisation therapy: from patient selection to monitorisationRecurrent atrial fibrillation in a cardiac resynchronisation therapy patient: role of remote monitoring for management strategy.H.Burri ( Geneva-Switzerland)Arrhythmias / Pacing / Resynchronisation28 Aug 2011
New evidence beyond guidelines in atrial fibrillationNew developments in the diagnosis of atrial fibrillation.G.Hindricks ( Leipzig-Germany)Arrhythmias / Pacing / Resynchronisation29 Aug 2011
New evidence beyond guidelines in atrial fibrillationNew antithrombotic therapies: revisiting stroke prevention in atrial fibrillation.L C.Wallentin ( Uppsala-Sweden)Arrhythmias / Pacing / Resynchronisation29 Aug 2011
New evidence beyond guidelines in atrial fibrillationWill catheter ablation of atrial fibrillation withstand the test of randomised studies.S.Ernst ( London-United Kingdom)Arrhythmias / Pacing / Resynchronisation29 Aug 2011
Hot Line II - Frontiers in interventional and device treatmentsECOST: Safety of implantable cardioverter defibrillator follow-up using remote monitoring: a randomized controlled trialS.Kacet ( Lille Cedex-France)Arrhythmias / Pacing / Resynchronisation29 Aug 2011
Hot Line II - Frontiers in interventional and device treatmentsDiscussant - ECOST: Safety of implantable cardioverter defibrillator follow-up using remote monitoring: a randomized controlled trialJ C.Daubert ( Rennes-France)Arrhythmias / Pacing / Resynchronisation29 Aug 2011
Anti-thrombotic therapy in atrial fibrillation - difficult management scenariosStroke and bleeding risk assessment in a high risk atrial fibrillation patient who needs a coronary stent.A.Rubboli ( Bologna-Italy)Arrhythmias / Pacing / Resynchronisation29 Aug 2011
Anti-thrombotic therapy in atrial fibrillation - difficult management scenariosThe 'truly low stroke risk' patient with atrial fibrillation: defining the population and what to do post-ablation.L.Fauchier ( Tours-France)Arrhythmias / Pacing / Resynchronisation29 Aug 2011
Controversial issues in cardiac resynchronisation therapyIs the optimisation of the atrioventricular and interventricular delays useful?D.Gras ( Nantes Cedex 2-France)Arrhythmias / Pacing / Resynchronisation29 Aug 2011
Controversial issues in cardiac resynchronisation therapyHow to manage cardiac resynchronisation therapy in atrial fibrillation patients?E K.Heist ( Boston-United States of America)Arrhythmias / Pacing / Resynchronisation29 Aug 2011
Controversial issues in cardiac resynchronisation therapyThe use of cardiac resynchronisation therapy outside current guidelines.RJ.van Bommel ( Leiden-Netherlands)Arrhythmias / Pacing / Resynchronisation29 Aug 2011
Clinical Trial Update II - Rate and rhythmPACE: Biventricular pacing superior to right ventricular pacing in bradycardia patients with preserved systolic function: two-year results of PACE trialCM.Yu ( Hong Kong-Hong Kong SAR, People's Republic of China)Arrhythmias / Pacing / Resynchronisation29 Aug 2011
Clinical Trial Update II - Rate and rhythmDiscussant - PACE: Biventricular pacing superior to right ventricular pacing in bradycardia patients with preserved systolic function: two-year results of PACE trialK.Dickstein ( Stavanger-Norway)Arrhythmias / Pacing / Resynchronisation29 Aug 2011
Clinical Trial Update II - Rate and rhythmDiscussant - IRIS: Why does the implantable cardioverter-defibrillator not improve mortality early after myocardial infarction - Insights from the Immediate Risk Stratification Improves Survival (IRIS) trialC.Leclercq ( Rennes-France)Arrhythmias / Pacing / Resynchronisation29 Aug 2011
State of the Art - Featured research on genetic aspects of cardiac arrhythmiasA rare variant in MYH6 confers high risk of sick sinus syndromeH.Holm ( Mosfellsbaer-Iceland)Arrhythmias / Pacing / Resynchronisation29 Aug 2011
State of the Art - Featured research on genetic aspects of cardiac arrhythmiasA dominant negative missense mutation in MOG1 induces trafficking defect of cardiac sodium channel and is associated with Brugada syndrome ECG patternD.Kattygnarath ( Paris-France)Arrhythmias / Pacing / Resynchronisation29 Aug 2011
State of the Art - Featured research on genetic aspects of cardiac arrhythmiasState of the Art - Featured research on genetic aspects of cardiac arrhythmiasP J.Schwartz ( Pavia-Italy)Arrhythmias / Pacing / Resynchronisation29 Aug 2011
CRH II - Interventions and devicesThe European CRT survey: 1 year follow-up resultsN.Bogale ( Sandnes-Norway)Arrhythmias / Pacing / Resynchronisation29 Aug 2011
EURObservational Research Programme of the ESC. Ongoing RegistriesSentinel Registry: Ablation in Atrial Fibrillation.J.Brugada Terradellas ( Barcelona-Spain)Arrhythmias / Pacing / Resynchronisation30 Aug 2011

 ESC Congress 2009 - Barcelona


Presentation TitleSpeakerTopicDate
Arrhythmia and pacing.J Brugada Terradellas (Barcelona, ES)Arrhythmias / Pacing / Resynchronisation01 Sep 2009
A randomized trial of dabigatran, a oral direct thrombin inhibitor, compared to warfarin in 18,113 patients with atrial fibrillation at high risk of stroke.S J Connolly (Hamilton, CA)Arrhythmias / Pacing / Resynchronisation30 Aug 2009
A randomized trial of dabigatran, a oral direct thrombin inhibitor, compared to warfarin in 18,113 patients with atrial fibrillation at high risk of stroke.: Discussant.A J Camm (London, GB)Arrhythmias / Pacing / Resynchronisation30 Aug 2009
A randomized evaluation of irbesartan versus placebo in patients with Atrial Fibrillation (factorial design of ACTIVE Program).S Yusuf (Hamilton, CA)Arrhythmias / Pacing / Resynchronisation01 Sep 2009
ACTIVE Program: Discussant.J Brugada Terradellas (Barcelona, ES)Arrhythmias / Pacing / Resynchronisation01 Sep 2009
European CRT Survey.N Bogale (Stavanger, NO)Arrhythmias / Pacing / Resynchronisation01 Sep 2009
European CRT Survery: Discussant.J C Daubert (Rennes, FR)Arrhythmias / Pacing / Resynchronisation01 Sep 2009
Prevention of Sudden Cardiac Death in Post Myocardial Infarction Patients: Risk Stratification, ICD Therapy Penetration and Related Longterm Outcome: Final Results of the German PreSCD II Registry.H Voeller (Rudersdorf, DE)Arrhythmias / Pacing / Resynchronisation01 Sep 2009
German PreSCD II Registry: Discussant.P E Vardas (Heraklion, GR)Arrhythmias / Pacing / Resynchronisation01 Sep 2009
ESC Guidelines for the management of syncope.A Moya I Mitjans (Barcelona, ES)Arrhythmias / Pacing / Resynchronisation30 Aug 2009
Risk stratification and diagnostic strategy in patients with syncope.A Moya I Mitjans (Barcelona, ES)Arrhythmias / Pacing / Resynchronisation30 Aug 2009
Syncope unit: utopia or a necessity.M Brignole (Lavagna, IT)Arrhythmias / Pacing / Resynchronisation30 Aug 2009
Specific aspects of syncope in the elderly: a growing problem.A Ungar (Firenze, IT)Arrhythmias / Pacing / Resynchronisation30 Aug 2009
Future directions in diagnosis and management of syncope.D G Benditt (Minneapolis, US)Arrhythmias / Pacing / Resynchronisation30 Aug 2009
Stroke prevention in atrial fibrillation: who should be on more than aspirin?J W Mant (Cambridge, GB)Arrhythmias / Pacing / Resynchronisation01 Sep 2009
Effects of rosuvastatin on atrial fibrillation occurrence: ancillary results of the GISSI-HF trial.A P Maggioni (Florence, IT)Arrhythmias / Pacing / Resynchronisation30 Aug 2009
GISSI-HF: Discussant.HJGM Crijns (Maastricht, NL)Arrhythmias / Pacing / Resynchronisation30 Aug 2009
Characteristics of patients enrolled in the Predictors of Response to CRT (PROSPECT) trial: comparison of subgroups according to extent of LV reverse remodeling.RJ van Bommel (Leiden, NL)Arrhythmias / Pacing / Resynchronisation30 Aug 2009
PROSPECT: Discussant.C Linde (Stockholm, SE)Arrhythmias / Pacing / Resynchronisation30 Aug 2009
Cardiac Resynchronization Therapy Induces Major Structural and Functional Reverse Remodeling In Mild Heart Failure. 24 month results of the REVERSE trial.S Ghio (Pavia, IT)Arrhythmias / Pacing / Resynchronisation30 Aug 2009
REVERSE: Discussant.J G F Cleland (Kingston upon Hull, GB)Arrhythmias / Pacing / Resynchronisation30 Aug 2009
RE-LY: Discussant.J-P Collet (Paris, FR)Arrhythmias / Pacing / Resynchronisation02 Sep 2009
Arrhythmias: Highlight SessionP E Vardas (Heraklion, GR)Arrhythmias / Pacing / Resynchronisation02 Sep 2009
Cardiac resynchronisation therapy in patients with mild heart failure.C Linde (Stockholm, SE)Arrhythmias / Pacing / Resynchronisation31 Aug 2009
Cardiac resynchronisation therapy in heart failure patients with atrial fibrillation.A Auricchio (Lugano, CH)Arrhythmias / Pacing / Resynchronisation31 Aug 2009
Left-ventricular based pacing for bradycardia.E Simantirakis (Heraklion, GR)Arrhythmias / Pacing / Resynchronisation31 Aug 2009
Upgrading conventional pacing to biventricular pacing.L Mont (Barcelona, ES)Arrhythmias / Pacing / Resynchronisation31 Aug 2009
Comparison between the effects of dabigatran versus warfarin in Vitamin K antagonist naïve and experienced patients with atrial fibrillation in the the RE-LY Trial.Michael D EzekowitzArrhythmias / Pacing / Resynchronisation02 Sep 2009
A rare variant in MYH6 confers high risk of sick sinus syndromeH.Holm ( Mosfellsbaer-Iceland)Genetic aspects of arrhythmias29 Aug 2011
A dominant negative missense mutation in MOG1 induces trafficking defect of cardiac sodium channel and is associated with Brugada syndrome ECG patternD.Kattygnarath ( Paris-France)Genetic aspects of arrhythmias29 Aug 2011
State of the Art - Featured research on genetic aspects of cardiac arrhythmiasP J.Schwartz ( Pavia-Italy)Mechanisms of arrhythmias29 Aug 2011

ESC Congress 2008 - Munich

 Arrhythmias


Session TitleTitleSpeaker
Moving from cure to palliationEnd of life issues in implantable cardioverter-defibrillator patients.Liu P (Toronto, CA)
Highlight SessionArrhythmias.Vardas P E (Heraklion, GR)

 Atrial Fibrillation


Session TitleTitleSpeaker
Management of atrial fibrillation in the elderlyMedical management of atrial fibrillation: what is different?Raviele A (Mestre, IT)
Management of atrial fibrillation in the elderlyPacemakers and atrioventricular node ablation.Willems R (Leuven, BE)
Management of atrial fibrillation in the elderlyPulmonary vein isolation: for which patients?Kottkamp H (Zurich, CH)
Clinical Trial Update IIAtrial Fibrillation and Congestive Heart Failure (AF-CHF) Trial - Discussant.Maggioni A P (Florence, IT)
State of the Art - Atrial fibrillation ablation: cutting edgeLeft atrial posterior wall isolation does not improve the outcome of circumferential pulmonary vein ablation for atrial fibrillation: a prospective randomized study.Tamborero Noguera D (Barcelona, ES)
State of the Art - Atrial fibrillation ablation: cutting edgeCatheter ablation of left atrial ganglionate plexi: long-term results.Pokuschalov E (Novosibirsk, RU)
State of the Art - Atrial fibrillation ablation: cutting edgeUsing 3D delayed-enhancement MRI to identify gap lesions following failed pulmonary vein isolation to help guide repeat radiofrequency ablation in atrial fibrillation patients.Badger TJ (Midvale, US)
State of the Art - Atrial fibrillation ablation: cutting edgeState of the Art - Atrial fibrillation ablation: cutting edge.Brugada Terradellas P (Brussels, BE)
Clinical Trial Update IIIATHENA: The effect of dronedarone on cardiovascular outcomes and stroke in patients with atrial fibrillation.Connolly S J (Hamilton, CA)
Clinical Trial Update IIIATHENA: The effect of dronedarone on cardiovascular outcomes and stroke in patients with atrial fibrillation. - Discussant.Kuck K-H (Hamburg, DE)

 Sudden Cardiac Death


Session TitleTitleSpeaker
ESC Rene Laennec Lecture on Clinical CardiologyUnderstanding sudden cardiac death: from the surface ECG to ion channels' genes.Schwartz P J (Pavia, IT)